Literature DB >> 16988268

Immunization with polyamine transport protein PotD protects mice against systemic infection with Streptococcus pneumoniae.

P Shah1, E Swiatlo.   

Abstract

The human pathogen Streptococcus pneumoniae contains genes for a putative polyamine ABC transporter which are organized in an operon and designated potABCD. Polyamine transport protein D (PotD) is an extracellular protein which binds polyamines and possibly other structurally related molecules. PotD has been shown to contribute to virulence in both a murine sepsis model and a pneumonia model with capsular type 3 pneumococci. The protective efficacy of recombinant PotD was evaluated by active immunization and intravenous challenge with capsular type 3 pneumococci in CBA/N mice. Immunized mice had 91.7% survival following lethal pneumococcal challenge, compared with 100% mortality in the control group. Immunized animals had high-titer anti-PotD antibodies following three immunizations with alum. Protection in a sepsis model was also seen after passive administration of rabbit antiserum raised against PotD (P < 0.004). These results suggest that antibodies to PotD confer protection against invasive pneumococcal disease and that this protein should be studied further as a potential vaccine candidate for protection against invasive pneumococcal infections.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16988268      PMCID: PMC1594930          DOI: 10.1128/IAI.00553-06

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  35 in total

1.  Pneumococcal disease and the role of conjugate vaccines.

Authors:  D L Klein
Journal:  Microb Drug Resist       Date:  1999       Impact factor: 3.431

2.  Immunization with alpha-toxin toxoid protects the cornea against tissue damage during experimental Staphylococcus aureus keratitis.

Authors:  E B Hume; J J Dajcs; J M Moreau; R J O'Callaghan
Journal:  Infect Immun       Date:  2000-10       Impact factor: 3.441

3.  Clinical effectiveness of pneumococcal vaccine. Meta-analysis.

Authors:  B G Hutchison; A D Oxman; H S Shannon; S Lloyd; C A Altmayer; K Thomas
Journal:  Can Fam Physician       Date:  1999-10       Impact factor: 3.275

4.  Complete genome sequence of a virulent isolate of Streptococcus pneumoniae.

Authors:  H Tettelin; K E Nelson; I T Paulsen; J A Eisen; T D Read; S Peterson; J Heidelberg; R T DeBoy; D H Haft; R J Dodson; A S Durkin; M Gwinn; J F Kolonay; W C Nelson; J D Peterson; L A Umayam; O White; S L Salzberg; M R Lewis; D Radune; E Holtzapple; H Khouri; A M Wolf; T R Utterback; C L Hansen; L A McDonald; T V Feldblyum; S Angiuoli; T Dickinson; E K Hickey; I E Holt; B J Loftus; F Yang; H O Smith; J C Venter; B A Dougherty; D A Morrison; S K Hollingshead; C M Fraser
Journal:  Science       Date:  2001-07-20       Impact factor: 47.728

5.  Contribution of novel choline-binding proteins to adherence, colonization and immunogenicity of Streptococcus pneumoniae.

Authors:  C Rosenow; P Ryan; J N Weiser; S Johnson; P Fontan; A Ortqvist; H R Masure
Journal:  Mol Microbiol       Date:  1997-09       Impact factor: 3.501

6.  Cellular location of polyamine transport protein PotD in Streptococcus pneumoniae.

Authors:  Pratik Shah; Mary Marquart; Lisa R Quin; Edwin Swiatlo
Journal:  FEMS Microbiol Lett       Date:  2006-08       Impact factor: 2.742

7.  Role of pneumococcal surface protein C in nasopharyngeal carriage and pneumonia and its ability to elicit protection against carriage of Streptococcus pneumoniae.

Authors:  Priya Balachandran; Alexis Brooks-Walter; Anni Virolainen-Julkunen; Susan K Hollingshead; David E Briles
Journal:  Infect Immun       Date:  2002-05       Impact factor: 3.441

Review 8.  The burden of pneumococcal disease among adults in developed and developing countries: what is and is not known.

Authors:  D S Fedson; J A Scott; G Scott
Journal:  Vaccine       Date:  1999-07-30       Impact factor: 3.641

9.  Effectiveness of pneumococcal polysaccharide vaccine in older adults.

Authors:  Lisa A Jackson; Kathleen M Neuzil; Onchee Yu; Patti Benson; William E Barlow; Annette L Adams; Christi A Hanson; Lisa D Mahoney; David K Shay; William W Thompson
Journal:  N Engl J Med       Date:  2003-05-01       Impact factor: 91.245

Review 10.  Novel vaccine strategies with protein antigens of Streptococcus pneumoniae.

Authors:  Edwin Swiatlo; Daphne Ware
Journal:  FEMS Immunol Med Microbiol       Date:  2003-08-18
View more
  24 in total

Review 1.  Next generation pneumococcal vaccines.

Authors:  Kristin L Moffitt; Richard Malley
Journal:  Curr Opin Immunol       Date:  2011-04-21       Impact factor: 7.486

2.  Identification of SP1683 as a pneumococcal protein that is protective against nasopharyngeal colonization.

Authors:  Leen Moens; Philippe Hermand; Tine Wellens; Greet Wuyts; Rita Derua; Etienne Waelkens; Carine Ysebaert; Fabrice Godfroid; Xavier Bossuyt
Journal:  Hum Vaccin Immunother       Date:  2018-02-21       Impact factor: 3.452

3.  Active Immunization with Pneumolysin versus 23-Valent Polysaccharide Vaccine for Streptococcus pneumoniae Keratitis.

Authors:  Erin W Norcross; Melissa E Sanders; Quincy C Moore; Sidney D Taylor; Nathan A Tullos; Rhonda R Caston; Sherrina N Dixon; Moon H Nahm; Robert L Burton; Hilary Thompson; Larry S McDaniel; Mary E Marquart
Journal:  Invest Ophthalmol Vis Sci       Date:  2011-11-29       Impact factor: 4.799

4.  Spermidine biosynthesis and transport modulate pneumococcal autolysis.

Authors:  Adam J Potter; James C Paton
Journal:  J Bacteriol       Date:  2014-08-04       Impact factor: 3.490

5.  Identification of a LolC homologue in Burkholderia pseudomallei, a novel protective antigen for melioidosis.

Authors:  David N Harland; Karen Chu; Ashraful Haque; Michelle Nelson; Nicola J Walker; Mitali Sarkar-Tyson; Timothy P Atkins; Benjamin Moore; Katherine A Brown; Gregory Bancroft; Richard W Titball; Helen S Atkins
Journal:  Infect Immun       Date:  2007-05-21       Impact factor: 3.441

6.  Microarray-based comparative genomic profiling of reference strains and selected Canadian field isolates of Actinobacillus pleuropneumoniae.

Authors:  Julien Gouré; Wendy A Findlay; Vincent Deslandes; Anne Bouevitch; Simon J Foote; Janet I MacInnes; James W Coulton; John H E Nash; Mario Jacques
Journal:  BMC Genomics       Date:  2009-02-24       Impact factor: 3.969

7.  ATP-Binding Cassette Systems of Brucella.

Authors:  Dominic C Jenner; Elie Dassa; Adrian M Whatmore; Helen S Atkins
Journal:  Comp Funct Genomics       Date:  2010-02-11

8.  Identification of conserved antigens for early serodiagnosis of relapsing fever Borrelia.

Authors:  Job E Lopez; Stephen F Porcella; Merry E Schrumpf; Sandra J Raffel; Carl H Hammer; Ming Zhao; Mary Ann Robinson; Tom G Schwan
Journal:  Microbiology (Reading)       Date:  2009-05-14       Impact factor: 2.777

9.  Immunoproteomic analysis of outer membrane proteins and extracellular proteins of Actinobacillus pleuropneumoniae JL03 serotype 3.

Authors:  Yonghong Liao; Junhua Deng; Anding Zhang; Mingguang Zhou; Yong Hu; Huanchun Chen; Meilin Jin
Journal:  BMC Microbiol       Date:  2009-08-20       Impact factor: 3.605

Review 10.  Development of Burkholderia mallei and pseudomallei vaccines.

Authors:  Ediane B Silva; Steven W Dow
Journal:  Front Cell Infect Microbiol       Date:  2013-03-11       Impact factor: 5.293

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.